virus sensing
virus entry
influenza virus sensors
dynamic nanoparticle shells
situ virus detection
animal virus strains
artificial virus particles
multivalent interactions
switchable shells
use of rSAMs
multivalent targets
dynamic nature of non-
generation dynamic shell nanoparticles
multivalent inhibition of viruses
proposal
nanoplasmonic sensors
infection assays
Current drug design
current systems ligands
respect
high density of ligands
high-affinity inhibitors
classical drug design
multiple weak interactions
pH responsiveness
pH-switchable versions of thiol
biological targets
multivalency concept
ligand distribution
benchmark assays
early stages of infection
subtyping capability
human
Reversible Self-assembled Monolayers
antibody-free ultrasensitive
stability
layer order
efficiency
head group
amidines
composition
dendritic architectures
assemblies
selectivity
diagnostics
enhanced affinities
Ebola
saccharides
antiviral drugs
biointerfaces
series of saccharide
lipid bilayers
control
contrast
model pathogens
biointerfacial receptors
main aims
particle surface
strategy